Burgdorf - Sanofi-Aventis has confirmed the order volumes for calendar year 2008 for the successfully launched and established pen systems: OptiSet, OptiClik and OptiPen Pro. Richard Fritschi, Ypsomed CEO, is pleased: “The confirmed orders for 2008 by Sanofi-Aventis are within our expectations, but - as announced earlier - lower than in the past year. The discussions with Sanofi-Aventis have been very constructive and confirm that Ypsomed will remain an important supplier to Sanofi-Aventis.”
The Sanofi-Aventis order volumes as well as the strong growth of the pen system business with other pharma customers and of the pen needle business fully utilises the current employee capacity. On 8th November 2007 Ypsomed will provide information on its semi-annual results 2007/08 and future company development.
Press Releases Ypsomed Group
